Pioglitazone Containing Medicines: Ongoing Safety Review For A Potential Increased Risk of Bladder Cancer
June 20, 2011 – The American Food and Drug Administration (FDA) informed recently (on June 15, 2011) that the use of the diabetes medication Pioglitazone [Actos] for more than one year may be associated with an increased risk of bladder …